BIOLASE Technology (BLIT) Receives FDA 510(k) Clearance

BIOLASE Technology, Inc. (Nasdaq: BLTI) received 510(k) clearance from the FDA allowing it to market a version of its Waterlase MD Laser System for use in dermatological applications as well as general and plastic surgery.

You May Also Be Interested In

• Charlie's Holdings names Henry Sicignano CEO amid leadership shift
• Quantum computing to reach $7-10B market by 2030, says BTIG
• Jefferies sees Japan value stocks gain as momentum trades reverse